NEUROCRINE BIOSCIENCES INC - 23 Feb 2023 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role
10%+ Owner
Signature
/s/ Darin Lippoldt, Chief Legal Officer & Corporate Secretary
Issuer symbol
VYGR
Transactions as of
23 Feb 2023
Net transactions value
+$39,032,821
Form type
4
Filing time
24 Feb 2023, 05:15:24 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYGR Common Stock Purchase $39,032,821 +4,395,588 +105% $8.88 8,575,316 23 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase price was determined in accordance with that certain Stock Purchase Agreement dated January 8, 2023, between the reporting person and the issuer.